Kinder Leslie S, Katon Wayne J, Ludman Evette, Russo Joan, Simon Greg, Lin Elizabeth H B, Ciechanowski Paul, Von Korff Michael, Young Bessie
Health Services Research and Development, Veterans Affairs Puget Sound Health Care System, Seattle, WA 98101, USA.
J Gen Intern Med. 2006 Oct;21(10):1036-41. doi: 10.1111/j.1525-1497.2006.00552.x. Epub 2006 Jul 7.
Depression is common in patients with diabetes, but it is often inadequately treated within primary care. Competing clinical demands and treatment resistance may make it especially difficult to improve depressive symptoms in patients with diabetes who have multiple complications.
To determine whether a collaborative care intervention for depression would be as effective in patients with diabetes who had 2 or more complications as in patients with diabetes who had fewer complications.
The Pathways Study was a randomized control trial comparing collaborative care case management for depression and usual primary care. This secondary analysis compared outcomes in patients with 2 or more complications to patients with fewer complications.
Three hundred and twenty-nine patients with diabetes and comorbid depression were recruited through primary care clinics of a large prepaid health plan.
Depression was assessed at baseline, 3, 6, and 12 months with the 20-item depression scale from the Hopkins Symptom Checklist. Diabetes complications were determined from automated patient records.
The Pathways collaborative care intervention was significantly more successful at reducing depressive symptoms than usual primary care in patients with diabetes who had 2 or more complications. Patients with fewer than 2 complications experienced similar reductions in depressive symptoms in both intervention and usual care.
Patients with depression and diabetes who have multiple complications may benefit most from collaborative care for depression. These findings suggest that with appropriate intervention depression can be successfully treated in patients with diabetes who have the highest severity of medical problems.
抑郁症在糖尿病患者中很常见,但在初级保健中往往治疗不足。相互竞争的临床需求和治疗抵抗可能使改善患有多种并发症的糖尿病患者的抑郁症状尤其困难。
确定针对抑郁症的协作护理干预对患有2种或更多并发症的糖尿病患者是否与患有较少并发症的糖尿病患者同样有效。
路径研究是一项随机对照试验,比较抑郁症协作护理病例管理与常规初级保健。这项二次分析比较了患有2种或更多并发症的患者与患有较少并发症的患者的结局。
通过一个大型预付费健康计划的初级保健诊所招募了329名患有糖尿病和共病抑郁症的患者。
在基线、3个月、6个月和12个月时,使用霍普金斯症状清单中的20项抑郁量表评估抑郁症。糖尿病并发症由患者自动记录确定。
在患有2种或更多并发症的糖尿病患者中,路径协作护理干预在减轻抑郁症状方面比常规初级保健显著更成功。并发症少于2种的患者在干预组和常规护理组中抑郁症状的减轻程度相似。
患有多种并发症的抑郁症和糖尿病患者可能从抑郁症协作护理中获益最大。这些发现表明,通过适当干预,患有最严重医疗问题的糖尿病患者的抑郁症可以得到成功治疗。